Searched for
DENGUE VACCINE
India moves closer to dengue vaccine as final trials underwayAn Indian vaccine candidate, DengiAll, is in its final testing phase. This single-dose shot offers hope against the deadly dengue disease. ...- Phase-3 clinical trial enrolment for India's first dengue vaccine to be completed by October: ICMRIndia's DengiAll vaccine trial is nearing completion. ICMR scientists anticipate enrolling 10,500 participants by October across 20 Indian ...
- Takeda to launch dengue vaccine in India next yearTakeda, a Japanese pharmaceutical company, plans to launch its dengue vaccine, Qdenga, in India next year in collaboration with Biological ...
- In a medical breakthrough, first phase-3 dengue vaccine trial begins in IndiaIndia started its inaugural phase 3 clinical trial for the DengiAll dengue vaccine, developed by Panacea Biotec. The trial will include 10,...
- First-ever phase-three clinical trial for dengue vaccine initiated in IndiaThe Indian Council of Medical Research (ICMR) and Panacea Biotec have launched the first phase three clinical trial for an indigenous dengu...
- CDSCO panel gives nod for continuation of phase-II clinical trial of SII's dengue vaccineAn expert committee recommended continuation of phase-II clinical trial of Serum Institute of India's vaccine against dengue after successf...
- Takeda to soon start trials in India for dengue vaccineTakeda Pharmaceuticals' dengue vaccine assumes significance since the first vaccine ever licensed for dengue, developed by French drugmaker...
- Japan's Takeda in regulatory talks to launch dengue vaccine in IndiaThe Japanese drugmaker plans to scale up the production of its dengue vaccine Qdenga through a partnership with Indian vaccine maker Biolog...
- Takeda, Biological E enter manufacturing pact to produce 50 million doses of Dengue vaccineJapanese drug giant Takeda has partnered with Indian vaccine maker Biological E (BE) to manufacture its Dengue vaccine. BE will increase it...
- Sanofi continues to seek clinical trial waiver in India for controversial dengue vaccinePhase 3 trials are the last phase of clinical trials that a company conducts before it receives approval to market the drug here.
- Shared latest data on dengue vaccine with authorities: SanofiYesterday, the Philippines government ordered an investigation into the immunisation of more than 7.3 lakh children with the company's deng...
- Sun Pharma partners ICGEB to develop safer, cheaper dengue vaccineThis is the Mumbai-based company’s second collaboration focussed on the mosquito-borne virus, the first being its pact to develop a botanic...
- Sun Pharma, ICGEB tie up to develop dengue vaccineSun Pharma will fund and support further development of the vaccine candidate and existing ICGEB knowhow and patents.
- Why India is struggling to introduce dengue vaccinesThe ICGEB plans a larger vaccine trial on monkeys in America; the full-fledged human trial after that could cost more than Rs 100 crore.
- India waives large-scale clinical trials for Sanofi's dengue vaccineAn expert consultative committee of the Indian drug regulatory agency has waived a large-scale clinical trial for a dengue vaccine develope...
- Sanofi gets Philippines' approval to market dengue vaccineSanofi Pasteur said Food and Drug Administration of Philippines has granted marketing approval to its Dengvaxia vaccine to be licensed for ...
- Government may exempt Sanofi’s dengue vaccine from large-scale clinical trialsIf cleared, the step may eventually pave the way for Dengvaxia's availability via the wide government distribution system and private chann...
- World's first dengue vaccine gets nod after 20 years of researchThe injection can thwart all four types of the virus, which has appeared in Portugal, France, Florida and Japan recently, according to WHO.
- World's 1st dengue vaccine likely by 2015: SanofiCountry Head, Sanofi Pasteur, Stephan Barth, said dengue is a serious health concern in India, causing a significant but under-reported bur...
- Dengue vaccine tested on Indian adults, found safeThe study showed that 87% of Indian adults in trial were positive to dengue at enrolment, confirming the significant endemic nature of the ...
Load More
